While medication-assisted treatment is the recommended therapy for pregnant women addicted to opioids, medically supervised withdrawal is an option if a woman does not accept treatment, the American College of Obstetricians and Gynecologists said this week.
A new report finds spending on Medicaid-covered prescriptions for the treatment of opioid use disorder and opioid overdose increased dramatically between 2011 and 2016, according to NPR. The largest increase occurred after 2014.
Health and Human Services Secretary Tom Price’s description of medication-assisted treatment for addiction as “substituting one opioid for another” is inaccurate, according to addiction experts who have asked Price to “set the record straight.”
The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
Aetna is the latest health insurer to announce it will no longer require preauthorization for opioid addiction treatment, Kaiser Health News reports. The change takes effect this month and applies to commercial plans.